Today, Liang Ge is here to talk about BIO coin, and he believes that this coin has great potential.
In the wave of intersection between cryptocurrency and biotechnology, BIO coin has become a highly regarded emerging asset due to its unique positioning and technological innovation. As the core token in the decentralized science (DeSci) field, BIO coin not only carries the mission of promoting biotechnological innovation but also builds a transparent and collaborative research ecosystem through blockchain technology.
The BIO protocol breaks the funding barriers of traditional scientific research through DAO governance model, intellectual property tokenization, and inclusive participation mechanisms. Scientists, patients, and investors can jointly decide the project direction, and intangible assets such as patents and datasets are transformed into tradable digital assets, significantly reducing innovation costs. This model has attracted global research institutions and capital attention, accelerating breakthroughs in drug development, gene technology, and other fields.
The biotechnology industry is in a rapid development phase, and as its infrastructure, the demand for BIO coin grows with the industry expansion. Its supply is capped at 800 million, and its scarcity provides support for long-term value. Multiple authoritative institutions predict that by 2027, the price of BIO coin is expected to break $0.097, and may exceed $0.30 by 2030. The listings on mainstream exchanges such as Binance further enhance its liquidity and market recognition.
Although the prospects for BIO coin are broad, the R&D cycle in biotechnology is long and the uncertainty of results is high, investors need to be wary of liquidity risks. It is recommended to consider one's own risk tolerance, pay attention to the quarterly research progress of the project and the effectiveness of DAO governance, and lay out rationally. For long-term investors optimistic about the DeSci track, BIO coin may become a key tool for sharing the dividends of biotechnology.
Short-term volatility:
At the beginning of 2025, after BIO coin was listed on exchanges such as Binance, the price soared from $0.07 to $0.15, and then consolidated around $0.13.
Technical indicators show that if the price remains above $0.12, it may form a basis for sustained upward movement, with target prices pointing to $0.20-$0.28.
Long-term forecast:
2026: If the price stays above $0.18-$0.20, it may rise to $0.40, with support at $0.18.
2027-2028: Prices may stabilize in the range of $0.25-$0.50, with a target price of $0.60 in 2028.
2030: With ecosystem expansion and increased adoption, the price may approach $0.80, with support at $0.50.
Institutional support: The strategic investment from Binance Labs and listings on mainstream exchanges significantly enhance the credibility and liquidity of BIO coin. Liang Ge remains optimistic about this coin.
